Infinity Pharmaceuticals, Inc. Investors: Lead Plaintiff Deadline is Approaching in the Class Action Against Infinity Pharmaceuticals, Inc.; Contact Robbins LLP Today Infinity Pharmaceuticals, Inc. (INFI) Misled Investors Regarding its Business Prospects

Lead Plaintiff Deadline Approaching: Infinity Pharmaceuticals, Inc. Investors Should Contact Robbins LLP for Information About the Infinity Pharmaceuticals, Inc. Class Action Infinity Pharmaceuticals, Inc. (INFI) Misled Investors Regarding its Business Prospects

INFI Stockholders Should Contact Robbins LLP for Information About the Class Action Involving Infinity Pharmaceuticals, Inc. SAN DIEGO, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired Infinity...

INFI Stock News: Investors with Significant Losses in Infinity Pharmaceuticals, Inc. Should Contact Robbins LLP About Recovery SAN DIEGO, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired Infinity...

Infinity Pharmaceuticals, Inc. (INFI) Shareholder Notice: Robbins LLP Reminds Investors of Class Action Filed Against Infinity Pharmaceuticals, Inc. SAN DIEGO, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired Infinity...